Parkin negatively regulates JNK pathway in the dopaminergic neurons of Drosophila.
暂无分享,去创建一个
Jin Man Kim | Sunhong Kim | G. Cha | Myungjin Kim | Sung Bae Lee | K. Cho | Sunhong Kim | Jongkyeong Chung | Jongkyeong Chung | Jeehye Park | Guang-Ho Cha | Kyoung Sang Cho | Myungjin Kim | Jeehye Park | Eunji Lee | J. Kim | Eunji Lee | Jongkyeong Chung | Guang-Ho Cha
[1] Patrizia Rizzu,et al. Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.
[2] J. Andersen,et al. The Herbicide Paraquat Induces Dopaminergic Nigral Apoptosis through Sustained Activation of the JNK Pathway* , 2004, Journal of Biological Chemistry.
[3] W. Bender,et al. A Drosophila model of Parkinson's disease , 2000, Nature.
[4] H. Okano,et al. Reaper-mediated inhibition of DIAP1-induced DTRAF1 degradation results in activation of JNK in Drosophila , 2002, Nature Cell Biology.
[5] Jian Feng,et al. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. , 2004, Human molecular genetics.
[6] N. Hattori,et al. An Unfolded Putative Transmembrane Polypeptide, which Can Lead to Endoplasmic Reticulum Stress, Is a Substrate of Parkin , 2001, Cell.
[7] Y. Imai,et al. Parkin Suppresses Unfolded Protein Stress-induced Cell Death through Its E3 Ubiquitin-protein Ligase Activity* , 2000, The Journal of Biological Chemistry.
[8] Florence Friggi-Grelin,et al. Tissue‐specific developmental requirements of Drosophila tyrosine hydroxylase isoforms , 2003, Genesis.
[9] J. Hirsh,et al. Ectopic G-protein expression in dopamine and serotonin neurons blocks cocaine sensitization in Drosophila melanogaster , 2000, Current Biology.
[10] T. Iwatsubo,et al. Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[11] Isao Nishimura,et al. Parkin Suppresses Dopaminergic Neuron-Selective Neurotoxicity Induced by Pael-R in Drosophila , 2003, Neuron.
[12] M. Feany,et al. α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease , 2005, Nature Neuroscience.
[13] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[14] Ming-tao Li,et al. SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson’s disease , 2004, Neuroscience Research.
[15] R. Nussbaum,et al. Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1 , 2004, Science.
[16] C. Ross,et al. Parkin ubiquitinates the α-synuclein–interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease , 2001, Nature Medicine.
[17] M. Peifer,et al. The canonical Wg and JNK signaling cascades collaborate to promote both dorsal closure and ventral patterning. , 2000, Development.
[18] Shinsei Minoshima,et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.
[19] H. Koh,et al. Drosophila phosphoinositide-dependent kinase-1 regulates apoptosis and growth via the phosphoinositide 3-kinase-dependent signaling pathway , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[20] Andrew Lees,et al. Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease , 2004, Neuron.
[21] G. Mardon,et al. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress , 2004, Development.
[22] Nobutaka Hattori,et al. Ubiquitination of a New Form of α-Synuclein by Parkin from Human Brain: Implications for Parkinson's Disease , 2001, Science.
[23] Yili Yang,et al. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2 , 2002, Nature.
[24] J. Uney,et al. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[25] A. Lang,et al. Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.
[26] Barry Ganetzky,et al. On the relationship between senescence and age-related changes in two wild-type strains of Drosophila melanogaster , 1978, Experimental Gerontology.
[27] A. Abeliovich,et al. Parkin Is a Component of an SCF-like Ubiquitin Ligase Complex and Protects Postmitotic Neurons from Kainate Excitotoxicity , 2003, Neuron.
[28] É. Le Bourg,et al. Hypergravity and aging in Drosophila melanogaster. 4. Climbing activity. , 1992, Gerontology.
[29] Thomas Meitinger,et al. Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology , 2004, Neuron.
[30] R. Swerdlow,et al. Interaction Among Mitochondria, Mitogen‐Activated Protein Kinases, and Nuclear Factor‐κB in Cellular Models of Parkinson's Disease , 2000, Journal of neurochemistry.
[31] S. Minoshima,et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.
[32] H. Koh,et al. Cyclic AMP Inhibits Akt Activity by Blocking the Membrane Localization of PDK1* , 2001, The Journal of Biological Chemistry.
[33] John Q. Trojanowski,et al. Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease , 2001, Science.
[34] R. Pendleton,et al. Effects of pharmacological agents upon a transgenic model of Parkinson's disease in Drosophila melanogaster. , 2002, The Journal of pharmacology and experimental therapeutics.
[35] W. Engels,et al. A stable genomic source of P element transposase in Drosophila melanogaster. , 1988, Genetics.
[36] Florence Friggi-Grelin,et al. Tissue‐specific developmental requirements of Drosophila tyrosine hydroxylase isoforms , 2003, Genesis.
[37] W. Min,et al. Thioredoxin Promotes ASK1 Ubiquitination and Degradation to Inhibit ASK1-Mediated Apoptosis in a Redox Activity-Independent Manner , 2002, Circulation research.
[38] Pasko Rakic,et al. JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[39] J. Zeitlinger,et al. Thorax closure in Drosophila: involvement of Fos and the JNK pathway. , 1999, Development.
[40] M. Mlodzik,et al. Jun mediates Frizzled-induced R3/R4 cell fate distinction and planar polarity determination in the Drosophila eye. , 2000, Development.
[41] S. Tsuji,et al. Autosomal recessive juvenile parkinsonism , 2000, Brain and Development.
[42] P. Bork,et al. A novel transactivation domain in parkin. , 1999, Trends in biochemical sciences.
[43] T. Dawson,et al. Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[44] Georg Auburger,et al. The ubiquitin pathway in Parkinson's disease , 1998, Nature.
[45] J. C. Greene,et al. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[46] H. Bourbon,et al. hemipterous encodes a novel drosophila MAP kinase kinase, required for epithelial cell sheet movement , 1995, Cell.